medscape.com To view or add a comment, sign in I wanted to share key take-aways from the recent joint statement by hepatology and diabetes experts: Management of patients with type 2 diabetes and MASLD: an overview and joint statement (Chouik Y et al., 2025)
Upcoming large trials will tell us whether this is transformative or just interesting
Ascites is often a sign of liver failure that happens from the liver disease or cirrhosis
MAGIC (Mayo Anesthesia Gastric Imaging Collaborative) Collaborators
Legoux F, Bellet D, Daviaud C, El Morr Y, Darbois A, Niort K, et al
Reversing this pathophysiology and providing supportive care is accomplished through intramuscular epinephrine (increases systemic vascular resistance and decreases bronchoconstriction), intravenous H1/H2 blockers (decreases vasodilation and third-spacing), nebulized beta-agonists (relieves bronchospasm), intravenous glucocorticoids (anti-inflammatory), and intravenous fluids (intravascular resuscitation, increases cardiac output)